AUTM, Academia and The MedTech Conference powered by AdvaMed

Posted by Chris Yochim on March 14, 2018

Having spent the better part of my professional career nurturing relationships between big pharma and academia, it’s interesting to observe that there are still areas which are underserved. Case in point, the medical device industry is increasingly finding value in the halls of academia, especially those with powerhouse engineering departments. But who has time to walk the halls looking for PIs who may or may not be open to industry collaboration?

Read More

Don't miss the MedTech Innovator Road Tour!

Posted by Carly Dell on March 2, 2018

Twitter Road Tour Image.jpg

Looking to learn more about the top medical device, digital health and diagnostics innovators from your area? If you answered yes, then you can't miss the MedTech Innovator Road Tour!

Read More

Early-stage medtech venture investment is up, driven by digitally-enabled diagnostics. But is the market ready?

Posted by Sonal Shah | Deloitte Center for Health Solutions on February 26, 2018

Deloitte Guest Blog Feb.png

This post is brought to you by Deloitte’s “A view from the Center” Life Sciences and Health Care blog

In my role with the Center for Health Solutions, I spend a fair amount of time researching technology and exploring the impact new medical devices could have on the health care sector. I generally don’t get much first-hand experience with medical devices. That recently changed.

When I told my primary care doctor about some odd sensations I had been feeling in my chest, he suggested a remote monitoring device that plugs right into my smartphone. Anytime I experienced this feeling in my chest, no matter where I was, I could put my fingers on the device and it would transmit an EKG reading directly to my doctor. He could then track patterns and get to the bottom of my symptoms. This type of remote monitoring is far more effective at diagnosing arrhythmia than having a patient travel to a doctor’s office periodically for an EKG test—not to mention the time and expense this device could save both the doctor and the patient.

Given its potential to more accurately diagnose patients and improve health outcomes, it is not surprising that digitally-enabled diagnostics like this one have been attracting venture capital investments.

Read More

Now accepting Program Advisory Council applications

Posted by Carly Dell on February 2, 2018


Read More

21st Century Cures: One Year Later

Posted by Scott Whitaker on December 13, 2017

This week marks the one-year anniversary of a rarity in Washington, DC: enactment of a health care bill with bipartisan majorities in both the House and Senate; support of the Administration; as well as the backing of patients, physicians, hospitals, and the pharmaceutical and medical technology industries.

The 21st Century Cures Act, signed into law Dec. 13, 2016, is one of the most significant pieces of health care legislation in recent years. Designed to accelerate the discovery, development and delivery of life-saving and life-improving therapies for patients, the law includes a number of process reforms at FDA to improve the efficiency and predictability of the drug and medical device review processes as well as significant funding for new health care research at NIH.

Read More

Apply Now for the 2018 $500K MedTech Innovator Competition and Accelerator

Posted by Carly Dell on November 28, 2017


Screen Shot 2017-11-20 at 9.16.40 AM

MedTech Innovator, the industry’s nonprofit global competition and accelerator, announced their call for startup and emerging-growth companies to apply to its 2018 competition by the Jan. 26, 2018, deadline. MedTech Innovator will award more than $500,000 in cash prizes and scholarships during the competition.

Read More

Patients as Partners in Medical Device Development

Posted by Gaurav Sharma and Heather Strohl | Battelle on November 7, 2017

This post is brought to you by Battelle

Imagine you are paralyzed, and are given the opportunity to regain control of a few key hand gestures. Which ones would you choose first? A tight fist? A handshake?

How about a credit card swipe?

That was the surprising answer Ian Burkhart gave when researchers from Battelle’s NeuroLife team asked him what he would like to work on next. Ian, who was paralyzed in a diving accident in 2011, is the first person to test the NeuroLife technology. Using a chip implanted in Ian’s brain, a sophisticated computer algorithm that interprets brain signals, and a specialized sleeve that sends those signals to Ian’s muscles, NeuroLife has given Ian the ability to consciously control his hand, wrist and fingers.


Read More

A little less conversation (a little more action) in outcomes-based contracts?

Posted by Mary Cummins | Deloitte Consulting LLP on October 27, 2017

Deloitte Blog Post 10.19.png

This post is brought to you by Deloitte’s “A view from the Center” Life Sciences and Health Care blog

I’m recently back from AdvaMed’s annual conference (The MedTech Conference) where, as always, I was struck by the deep commitment to bring innovation to patients. But innovation is in the eye of the beholder. When it comes to medtech offerings, there are many stakeholders who decide if an innovation is going to deliver differentiated results, and what value is merited in return. We highlighted this in our work with AdvaMed and the industry on Effective Value Assessment. And innovation isn’t limited to devices or technology, or even services – innovation can also include novel contracting and business models.

Read More

A Look at the Future of MedTech Regulation: Recap of Dr. Scott Gottlieb’s Plenary Remarks

Posted by Lauren Belisle on October 11, 2017

As a physician, medical policy expert, and public health advocate, Dr. Scott Gottlieb brings a great deal of knowledge and experience to his new role as Commissioner of the U.S. Food and Drug Administration (FDA). During his plenary remarks at The MedTech Conference, Dr. Gottlieb discussed some of the FDA’s recent achievements, its current priorities and potential opportunities for further regulatory innovation.

Read More

Congratulations to Day Zero Diagnostics - MedTech Innovator 2017 Winner

Posted by Caroline Coulter on October 4, 2017



Selected by an onsite vote of almost 1,500 conference attendees, Boston-based company Day Zero Diagnostics was chosen as the winner of the 2017 MedTech Innovator Global Competition. Through combining genome sequencing and machine learning to battle antimicrobial resistant infections, Day Zero Diagnostics is allowing physicians to shift from broad-spectrum antibiotic therapy to a targeted antibiotic in hours instead of days.

Read More